Literature DB >> 25896766

ATP leakage induces P2XR activation and contributes to acute synaptic excitotoxicity induced by soluble oligomers of β-amyloid peptide in hippocampal neurons.

F Sáez-Orellana1, P A Godoy1, C Y Bastidas1, T Silva-Grecchi1, L Guzmán2, L G Aguayo2, J Fuentealba3.   

Abstract

Recent studies suggest that the toxic effects of Aβ can be attributed to its capability to insert in membranes and form pore-like structures, which are permeable to cations and molecules such as ATP. Our working hypothesis is that Aβ increases extracellular ATP causing activation of P2X receptors and potentiating excitatory synaptic activity. We found that soluble oligomers of β-amyloid peptide increased cytosolic Ca(2+) 4-fold above control (415 ± 28% of control). Also, ATP leakage (157 ± 10% of control) was independent of extracellular Ca(2+), suggesting that ATP traveled from the cytosol through an Aβ pore-mediated efflux and not from exocytotic mechanisms. The subsequent activation of P2XR by ATP can contribute to the cytosolic Ca(2+) increase observed with Aβ. Additionally, we found that β-amyloid oligomers bind preferentially to excitatory neurons inducing an increase in excitatory synaptic current frequency (248.1 ± 32.7%) that was blocked by the use of P2XR antagonists such as PPADS (Aβ + PPADS: 110.9 ± 18.35%) or Apyrase plus DPCPX (Aβ + inhibitors: 98.97 ± 17.4%). Taken together, we suggest that Aβ induces excitotoxicity by binding preferentially to excitatory neuron membranes forming a non-selective pore and by increasing intracellular calcium by itself and through P2XR activation by extracellular ATP leading to an augmention in mEPSC activity. All these effects were blocked with a non-specific P2XR antagonist, indicating that part of the neurotoxicity of Aβ is mediated by P2XR activation and facilitation of excitatory neurotransmitter release. These findings suggest that P2XR can be considered as a potential new target for the development of drugs or pharmacological tools to treat Alzheimer's disease. This article is part of the Special Issue entitled 'Synaptopathy--from Biology to Therapy'.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATP; Alzheimer's disease; Aβ peptide oligomer; P2X receptors

Mesh:

Substances:

Year:  2015        PMID: 25896766     DOI: 10.1016/j.neuropharm.2015.04.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  21 in total

Review 1.  The Role of Neuronal NLRP1 Inflammasome in Alzheimer's Disease: Bringing Neurons into the Neuroinflammation Game.

Authors:  Jeremy Kean Yi Yap; Benjamin Simon Pickard; Elaine Wan Ling Chan; Sook Yee Gan
Journal:  Mol Neurobiol       Date:  2019-05-20       Impact factor: 5.590

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 3.  Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.

Authors:  Alexia Duveau; Eléonore Bertin; Eric Boué-Grabot
Journal:  Neurosci Bull       Date:  2020-09-05       Impact factor: 5.203

4.  Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

Authors:  Irina Petrushina; Hayk Davtyan; Armine Hovakimyan; Arpine Davtyan; Giselle F Passos; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

5.  Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons.

Authors:  Gisele S Seixas da Silva; Helen M Melo; Mychael V Lourenco; Natalia M Lyra E Silva; Marcelo B de Carvalho; Soniza V Alves-Leon; Jorge M de Souza; William L Klein; Wagner S da-Silva; Sergio T Ferreira; Fernanda G De Felice
Journal:  J Biol Chem       Date:  2017-03-16       Impact factor: 5.157

6.  Soursop fruit extract mitigates scopolamine-induced amnesia and oxidative stress via activating cholinergic and Nrf2/HO-1 pathways.

Authors:  Naif E Al Omairi; Ashraf Y Al-Brakati; Rami B Kassab; Maha S Lokman; Ehab Kotb Elmahallawy; Hatem K Amin; Ahmed E Abdel Moneim
Journal:  Metab Brain Dis       Date:  2019-03-27       Impact factor: 3.584

Review 7.  Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.

Authors:  Vaibhav Walia; Deepak Kaushik; Vineet Mittal; Kuldeep Kumar; Ravinder Verma; Jatin Parashar; Rokeya Akter; Md Habibur Rahman; Saurabh Bhatia; Ahmed Al-Harrasi; Chenmala Karthika; Tanima Bhattacharya; Hitesh Chopra; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2021-11-09       Impact factor: 5.682

8.  P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease.

Authors:  Francisco Sáez-Orellana; María C Fuentes-Fuentes; Pamela A Godoy; Tiare Silva-Grecchi; Jessica D Panes; Leonardo Guzmán; Gonzalo E Yévenes; Javiera Gavilán; Terrance M Egan; Luis G Aguayo; Jorge Fuentealba
Journal:  Neuropharmacology       Date:  2017-10-25       Impact factor: 5.250

9.  Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells.

Authors:  Anna Drews; Jennie Flint; Nadia Shivji; Peter Jönsson; David Wirthensohn; Erwin De Genst; Cécile Vincke; Serge Muyldermans; Chris Dobson; David Klenerman
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

10.  Characterization of ATPase Activity of P2RX2 Cation Channel.

Authors:  Rahul Mittal; M'hamed Grati; Miloslav Sedlacek; Fenghua Yuan; Qing Chang; Denise Yan; Xi Lin; Bechara Kachar; Amjad Farooq; Prem Chapagain; Yanbin Zhang; Xue Z Liu
Journal:  Front Physiol       Date:  2016-05-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.